{"id":"https://openalex.org/W2006917640","doi":"https://doi.org/10.4088/jcp.v62n0410","title":"Long-Term Olanzapine Therapy in the Treatment of Bipolar I Disorder: An Open-Label Continuation Phase Study","display_name":"Long-Term Olanzapine Therapy in the Treatment of Bipolar I Disorder: An Open-Label Continuation Phase Study","alternate_titles":[],"publication_year":2001,"publication_date":"2001-04-15","ids":{"openalex":"https://openalex.org/W2006917640","doi":"https://doi.org/10.4088/jcp.v62n0410","mag":"2006917640","pmid":"https://pubmed.ncbi.nlm.nih.gov/11379842"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v62n0410","doi":"https://doi.org/10.4088/jcp.v62n0410","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v62n0410","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006917640"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053102161","display_name":"Todd M. Sanger","orcid":"https://orcid.org/0000-0002-1020-6374","observed_orcids":["https://orcid.org/0000-0002-1020-6374"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Todd M. Sanger","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011054933","display_name":"Starr L. Grundy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Starr L. Grundy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084015832","display_name":"P. Joseph Gibson","orcid":"https://orcid.org/0000-0001-9365-2881","observed_orcids":["https://orcid.org/0000-0001-9365-2881"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Joseph Gibson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010678498","display_name":"Madhav A. Namjoshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Madhav A. Namjoshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111897955","display_name":"Michael G. Greaney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael G. Greaney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5007497235","display_name":"Mauricio F. Tohen","orcid":"https://orcid.org/0000-0001-8049-4351","observed_orcids":["https://orcid.org/0000-0001-8049-4351"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mauricio F. Tohen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.1919,"has_fulltext":false,"cited_by_count":113,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98811747,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"62","issue":"4","first_page":"273","last_page":"281"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/bipolar-i-disorder","display_name":"bipolar I disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/long-term-maintenance-therapy","display_name":"long-term maintenance therapy","score":0.7910000085830688},{"id":"https://openalex.org/keywords/acute-mania","display_name":"acute mania","score":0.8759999871253967},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.44999998807907104},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.5009999871253967},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.996999979019165},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.7009999752044678},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.921999990940094},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7770000100135803},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2777089681","wikidata":"https://www.wikidata.org/wiki/Q4340609","display_name":"Young Mania Rating Scale","level":5,"score":0.9411279559135437},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8204355239868164},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5864409804344177},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.5817394256591797},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.5523850321769714},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5392985939979553},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5220317840576172},{"id":"https://openalex.org/C2778609679","wikidata":"https://www.wikidata.org/wiki/Q4915474","display_name":"Bipolar I disorder","level":5,"score":0.5190168619155884},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.507084846496582},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.4790036380290985},{"id":"https://openalex.org/C2780550438","wikidata":"https://www.wikidata.org/wiki/Q2622367","display_name":"Mood stabilizer","level":4,"score":0.4243970811367035},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3758825361728668},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3459983468055725},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.2968849539756775},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1903364658355713},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.12588903307914734},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.11717462539672852},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008094","descriptor_name":"Lithium","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012890","descriptor_name":"Sleep","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v62n0410","doi":"https://doi.org/10.4088/jcp.v62n0410","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v62n0410","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:11379842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11379842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W143382592","https://openalex.org/W147127941","https://openalex.org/W871677187","https://openalex.org/W1521535206","https://openalex.org/W1748132277","https://openalex.org/W1812467931","https://openalex.org/W1987320127","https://openalex.org/W1990172985","https://openalex.org/W1999689270","https://openalex.org/W2030034545","https://openalex.org/W2061378977","https://openalex.org/W2074559120","https://openalex.org/W2093053385","https://openalex.org/W2109442247","https://openalex.org/W2140606211","https://openalex.org/W2151872428","https://openalex.org/W2160703379","https://openalex.org/W2165379748","https://openalex.org/W2167659819","https://openalex.org/W2235811302","https://openalex.org/W2294950054","https://openalex.org/W2431767892","https://openalex.org/W3090293687","https://openalex.org/W3126849616"],"related_works":["https://openalex.org/W2129069620","https://openalex.org/W2168994605","https://openalex.org/W2135399947","https://openalex.org/W2112000785","https://openalex.org/W2063300114","https://openalex.org/W1807844756","https://openalex.org/W1990721010","https://openalex.org/W1999594051","https://openalex.org/W2121339106","https://openalex.org/W2034940841"],"abstract_inverted_index":{"BACKGROUND:":[0],"Olanzapine":[1],"has":[2],"demonstrated":[3,270],"efficacy":[4],"in":[5,11,169,214,260,273],"the":[6,18,21,48,55,60,64,71,78,84,92,99,109,112,117,133,144,170],"treatment":[7,49,129,153],"of":[8,20,26,35,50,63,151,162,186,191,224,253],"acute":[9,51],"mania":[10,274],"2":[12],"double-blind,":[13,284],"placebo-controlled":[14],"trials.":[15,28],"We":[16],"describe":[17],"results":[19],"open-label":[22,73,145],"extension":[23],"from":[24],"one":[25],"these":[27,291],"METHOD:":[29],"In":[30],"a":[31,158,189,279],"3-week,":[32],"double-blind":[33,61],"study":[34],"patients":[36,57,68,187,225,266],"with":[37,132,157,262,267,278],"DSM-IV":[38],"bipolar":[39,268],"I":[40],"disorder,":[41],"olanzapine":[42,135,152,229,254],"was":[43,154,181,217],"superior":[44],"to":[45,175,250,289],"placebo":[46],"for":[47,89],"manic":[52,192],"symptoms.":[53],"Of":[54],"139":[56],"who":[58],"entered":[59],"phase":[62],"3-week":[65],"study,":[66],"113":[67],"continued":[69],"into":[70],"49-week":[72],"extension.":[74,146],"Efficacy":[75],"measurements":[76,107],"including":[77,108],"Young":[79],"Mania":[80],"Rating":[81,87],"Scale":[82,88,104,121],"(YMRS),":[83],"21-item":[85],"Hamilton":[86],"Depression":[90],"(HAM-D-21),":[91],"Clinical":[93],"Global":[94],"Impressions":[95],"scale-Bipolar":[96],"Version,":[97],"and":[98,101,105,116,139,200,243,275],"Positive":[100],"Negative":[102],"Syndrome":[103],"safety":[106,281],"Simpson-Angus":[110],"scale,":[111],"Barnes":[113],"Akathisia":[114],"Scale,":[115],"Abnormal":[118],"Involuntary":[119],"Movement":[120],"were":[122,141,226,238],"completed":[123],"throughout.":[124],"The":[125,148,231],"analysis":[126],"considered":[127],"all":[128],"results,":[130],"starting":[131],"first":[134],"dose.":[136],"Adjunctive":[137],"lithium":[138,263],"fluoxetine":[140],"allowed":[142],"during":[143],"RESULTS:":[147],"mean":[149,159,167],"length":[150],"6.6":[155],"months,":[156],"modal":[160],"dose":[161],"13.9":[163],"mg/day.":[164],"A":[165],"significant":[166,271],"improvement":[168,213,272],"YMRS":[171],"total":[172,195,206],"score,":[173],"baseline":[174],"endpoint":[176],"(-18.01,":[177],"p":[178],"<":[179,197,220],".001),":[180],"observed.":[182],"During":[183,248],"treatment,":[184],"88.3%":[185],"experienced":[188],"remission":[190],"symptoms":[193,277],"(YMRS":[194,205],"score":[196,207],"or":[198,209,259],"=12),":[199],"only":[201],"25.5%":[202],"subsequently":[203],"relapsed":[204],">":[208],"=":[210],"15).":[211],"Significant":[212],"HAM-D-21":[215],"scores":[216],"observed":[218],"(p":[219],".001).":[221],"Forty-one":[222],"percent":[223],"maintained":[227],"on":[228],"monotherapy.":[230],"most":[232],"common":[233],"treatment-emergent":[234],"adverse":[235],"events":[236],"reported":[237],"somnolence":[239],"(46.0%),":[240],"depression":[241,276],"(38.9%),":[242],"weight":[244],"gain":[245],"(36.3%).":[246],"CONCLUSION:":[247],"up":[249],"1":[251],"year":[252],"therapy,":[255],"either":[256],"as":[257],"monotherapy":[258],"combination":[261],"and/or":[264],"fluoxetine,":[265],"disorder":[269],"favorable":[280],"profile.":[282],"Further":[283],"controlled":[285],"studies":[286],"are":[287],"needed":[288],"confirm":[290],"results.":[292]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006917640","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
